|
1
|
Miklavcic D and Davalos RV:
Electrochemotherapy (ECT) and irreversible electroporation (IRE)
-advanced techniques for treating deep-seated tumors based on
electroporation. Biomed Eng Online. 14 Suppl 3:I12015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Groselj A, Kos B, Cemazar M, Urbancic J,
Kragelj G, Bosnjak M, Veberic B, Strojan P, Miklavcic D and Sersa
G: Coupling treatment planning with navigation system: A new
technological approach in treatment of head and neck tumors by
electrochemotherapy. Biomed Eng Online. 14 Suppl 3:S22015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mir LM, Orlowski S, Belehradek J Jr and
Paoletti C: Electrochemotherapy potentiation of antitumour effect
of bleomycin by local electric pulses. Eur J Cancer. 27:68–72.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heller R, Gilbert R and Jaroszeski MJ:
Clinical applications of electrochemotherapy. Adv Drug Deliv Rev.
35:119–129. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heller R, Gilbert R and Jaroszeski MJ:
Electrochemotherapy: An emerging drug delivery method for the
treatment of cancer. Adv Drug Deliv Rev. 26:185–197. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mir LM, Banoun H and Paoletti C:
Introduction of definite amounts of nonpermeant molecules into
living cells after electropermeabilization: direct access to the
cytosol. Exp Cell Res. 175:15–25. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jaroszeski MJ, Dang V, Pottinger C, Hickey
J, Gilbert R and Heller R: Toxicity of anticancer agents mediated
by electroporation in vitro. Anticancer Drugs. 11:201–208. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rols MP, Delteil C, Golzio M, Dumond P,
Cros S and Teissie J: In vivo electrically mediated protein and
gene transfer in murine melanoma. Nat Biotechnol. 16:168–171. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mir LM, Bureau MF, Gehl J, Rangara R, Rouy
D, Caillaud JM, Delaere P, Branellec D, Schwartz B and Scherman D:
High-efficiency gene transfer into skeletal muscle mediated by
electric pulses. Proc Natl Acad Sci USA. 96:4262–4267. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heller R, Jaroszeski M, Atkin A, Moradpour
D, Gilbert R, Wands J and Nicolau C: In vivo gene electroinjection
and expression in rat liver. FEBS Lett. 389:225–228. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heller R, Jaroszeski MJ, Reintgen DS,
Puleo CA, DeConti RC, Gilbert RA and Glass LF: Treatment of
cutaneous and subcutaneous tumors with electrochemotherapy using
intralesional bleomycin. Cancer. 83:148–157. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Orlowski S and Mir LM: Cell
electropermeabilization: A new tool for biochemical and
pharmacological studies. Biochim Biophys Acta. 1154:51–63. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weaver JC: Electroporation: A general
phenomenon for manipulating cells and tissues. J Cell Biochem.
51:426–435. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edd JF, Horowitz L, Davalos RV, Mir LM and
Rubinsky B: In vivo results of a new focal tissue ablation
technique: irreversible electroporation. IEEE Trans Biomed Eng.
53:1409–1415. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nuccitelli R, Pliquett U, Chen X, Ford W,
Swanson James R, Beebe SJ, Kolb JF and Schoenbach KH: Nanosecond
pulsed electric fields cause melanomas to self-destruct. Biochem
Biophys Res Commun. 343:351–360. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weaver JC: Electroporation theory.
Concepts and mechanisms. Methods Mol Biol. 55:3–28. 1995.PubMed/NCBI
|
|
17
|
Neumann E, Schaefer-Ridder M, Wang Y and
Hofschneider PH: Gene transfer into mouse lyoma cells by
electroporation in high electric fields. EMBO J. 1:841–845.
1982.PubMed/NCBI
|
|
18
|
Pron G, Belehradek J Jr and Mir LM:
Identification of a plasma membrane protein that specifically binds
bleomycin. Biochem Biophys Res Commun. 194:333–337. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mir LM, Tounekti O and Orlowski S:
Bleomycin: Revival of an old drug. Gen Pharmacol. 27:745–748. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gehl J, Skovsgaard T and Mir LM:
Enhancement of cytotoxicity by electropermeabilization: An improved
method for screening drugs. Anticancer Drugs. 9:319–325. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Orlowski S, Belehradek J Jr, Paoletti C
and Mir LM: Transient electropermeabilization of cells in culture.
Increase of the cytotoxicity of anticancer drugs. Biochem
Pharmacol. 37:4727–4733. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Poddevin B, Orlowski S, Belehradek J Jr
and Mir LM: Very high cytotoxicity of bleomycin introduced into the
cytosol of cells in culture. Biochem Pharmacol. 42 Suppl:S67–S75.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hall SW, Strong JE, Broughton A, Frazier
ML and Benjamin RS: Bleomycin clinical pharmacology by
radioimmunoassay. Cancer Chemother Pharmacol. 9:22–25. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eljack ND, Ma HY, Drucker J, Shen C,
Hambley TW, New EJ, Friedrich T and Clarke RJ: Mechanisms of cell
uptake and toxicity of the anticancer drug cisplatin. Metallomics.
6:2126–2133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sersa G, Cemazar M and Miklavcic D:
Antitumor effectiveness of electrochemotherapy with
cis-diamminedichloroplatinum(II) in mice. Cancer Res. 55:3450–3455.
1995.PubMed/NCBI
|
|
26
|
Rodriguez-Cuevas S, Barroso-Bravo S,
Almanza-Estrada J, Cristobal-Martinez L and Gonzalez-Rodriguez E:
Electrochemotherapy in primary and metastatic skin tumors: Phase II
trial using intralesional bleomycin. Arch Med Res. 32:273–276.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Burian M, Formanek M and Regele H:
Electroporation therapy in head and neck cancer. Acta Otolaryngol.
123:264–268. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Umezawa H, Maeda K, Takeuchi T and Okami
Y: New antibiotics, bleomycin A and B. J Antibiot (Tokyo).
19:200–209. 1966.PubMed/NCBI
|
|
29
|
Dillman RO: Rationales for combining
chemotherapy and biotherapy in the treatment of cancer. Mol
Biother. 2:201–207. 1990.PubMed/NCBI
|
|
30
|
Tounekti O, Pron G, Belehradek J Jr and
Mir LM: Bleomycin, an apoptosis-mimetic drug that induces two types
of cell death depending on the number of molecules internalized.
Cancer Res. 53:5462–5469. 1993.PubMed/NCBI
|
|
31
|
Tounekti O, Kenani A, Foray N, Orlowski S
and Mir LM: The ratio of single- to double-strand DNA breaks and
their absolute values determine cell death pathway. Br J Cancer.
84:1272–1279. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Belehradek M, Domenge C, Luboinski B,
Orlowski S, Belehradek J Jr and Mir LM: Electrochemotherapy, a new
antitumor treatment. First clinical phase I–II trial. Cancer.
72:3694–3700. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mir LM, Belehradek M, Domenge C, Orlowski
S, Poddevin B, Belehradek J Jr, Schwaab G, Luboinski B and Paoletti
C: Electrochemotherapy, a new antitumor treatment: first clinical
trial. C R Acad Sci III. 313:613–618. 1991.(In French). PubMed/NCBI
|
|
34
|
Sersa G, Cufer T, Cemazar M, Rebersek M
and Zvonimir R: Electrochemotherapy with bleomycin in the treatment
of hypernephroma metastasis: Case report and literature review.
Tumori. 86:163–165. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Puc M, Corovic S, Flisar K, Petkovsek M,
Nastran J and Miklavcic D: Techniques of signal generation required
for electropermeabilization. Survey of electropermeabilization
devices. Bioelectrochemistry. 64:113–124. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mir LM, Glass LF, Sersa G, Teissié J,
Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reintgen DS,
Rudolf Z, et al: Effective treatment of cutaneous and subcutaneous
malignant tumours by electrochemotherapy. Br J Cancer.
77:2336–2342. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mir LM, Gehld J, Sersae G, et al: Standard
operating procedures of the electrochemotherapy: Instructions for
the use of bleomycin or cisplatin administered either systemically
or locally and electric pulses delivered by the Cliniporator by
means of invasive or non-invasive electrodes. EJC Supplements.
4:14–25. 2006. View Article : Google Scholar
|
|
38
|
Miklavcic D, Corovic S, Pucihar G and
Pavselj N: Importance of tumour coverage by sufficiently high local
electric field for effective electrochemotherapy. Eur J Cancer
Suppl. 4:45–51. 2006. View Article : Google Scholar
|
|
39
|
Domenge C, Orlowski S, Luboinski B, De
Baere T, Schwaab G, Belehradek J Jr and Mir LM: Antitumor
electrochemotherapy: New advances in the clinical protocol. Cancer.
77:956–963. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sersa G, Stabuc B, Cemazar M, Miklavcic D
and Rudolf Z: Electrochemotherapy with cisplatin: The systemic
antitumour effectiveness of cisplatin can be potentiated locally by
the application of electric pulses in the treatment of malignant
melanoma skin metastases. Melanoma Res. 10:381–385. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cemazar M, Milacic R, Miklavcic D, Dolzan
V and Sersa G: Intratumoral cisplatin administration in
electrochemotherapy: Antitumor effectiveness, sequence dependence
and platinum content. Anticancer Drugs. 9:525–530. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Heller R, Jaroszeski M, Perrott R, Messina
J and Gilbert R: Effective treatment of B16 melanoma by direct
delivery of bleomycin using electrochemotherapy. Melanoma Res.
7:10–18. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mir LM: Electroporation-based gene
therapy: Recent evolution in the mechanism description and
technology developments. Methods Mol Biol. 1121:3–23. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sersa G, Cemazar M, Parkins CS and Chaplin
DJ: Tumour blood flow changes induced by application of electric
pulses. Eur J Cancer. 35:672–677. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gehl J and Geertsen PF: Efficient
palliation of haemorrhaging malignant melanoma skin metastases by
electrochemotherapy. Melanoma Res. 10:585–589. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cemazar M, Parkins CS, Holder AL, Chaplin
DJ, Tozer GM and Sersa G: Electroporation of human microvascular
endothelial cells: Evidence for an anti-vascular mechanism of
electrochemotherapy. Br J Cancer. 84:565–570. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mir LM, Orlowski S, Poddevin B and
Belehradek J Jr: Electrochemotherapy tumor treatment is improved by
interleukin-2 stimulation of the host's defenses. Eur Cytokine
Netw. 3:331–334. 1992.PubMed/NCBI
|
|
48
|
Orlowski S, An D, Belehradek J Jr and Mir
LM: Antimetastatic effects of electrochemotherapy and of
histoincompatible interleukin-2-secreting cells in the murine Lewis
lung tumor. Anticancer Drugs. 9:551–556. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mir LM, Roth C, Orlowski S,
Quintin-Colonna F, Fradelizi D, Belehradek J Jr and Kourilsky P:
Systemic antitumor effects of electrochemotherapy combined with
histoincompatible cells secreting interleukin-2. J Immunother
Emphasis Tumor Immunol. 17:30–38. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ramirez LH, Orlowski S, An D, Bindoula G,
Dzodic R, Ardouin P, Bognel C, Belehradek J Jr, Munck JN and Mir
LM: Electrochemotherapy on liver tumours in rabbits. Br J Cancer.
77:2104–2111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Heller L, Pottinger C, Jaroszeski MJ,
Gilbert R and Heller R: In vivo electroporation of plasmids
encoding GM-CSF or interleukin-2 into existing B16 melanomas
combined with electrochemotherapy induces long-term antitumour
immunity. Melanoma Res. 10:577–583. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sersa G, Cemazar M, Menart V,
Gaberc-Porekar V and Miklavcic D: Anti-tumor effectiveness of
electrochemotherapy with bleomycin is increased by TNF-alpha on
SA-1 tumors in mice. Cancer Lett. 116:85–92. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Allegretti JP and Panje WR:
Electroporation therapy for head and neck cancer including carotid
artery involvement. Laryngoscope. 111:52–56. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
De Virgilio A, Fusconi M, Greco A and de
Vincentiis M: The role of electrochemotherapy in the treatment of
metastatic head and neck cancer. Tumori. 99:6342013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rols MP, Bachaud JM, Giraud P, Chevreau C,
Roche H and Teissie J: Electrochemotherapy of cutaneous metastases
in malignant melanoma. Melanoma Res. 10:468–474. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Snoj M, Cemazar M, Kolar Slekovec B and
Sersa G: Effective treatment of multiple unresectable skin melanoma
metastases by electrochemotherapy. Croat Med J. 48:391–395.
2007.PubMed/NCBI
|
|
57
|
Wapnir IL, Wartenberg DE and Greco RS:
Three dimensional staging of breast cancer. Breast Cancer Res
Treat. 41:15–19. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tomayko MM and Reynolds CP: Determination
of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother
Pharmacol. 24:148–154. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Heller R, Jaroszeski MJ, Glass LF, Messina
JL, Rapaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM and
Reintgen DS: Phase I/II trial for the treatment of cutaneous and
subcutaneous tumors using electrochemotherapy. Cancer. 77:964–971.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kubota Y, Mir LM, Nakada T, Sasagawa I,
Suzuki H and Aoyama N: Successful treatment of metastatic skin
lesions with electrochemotherapy. J Urol. 160:14261998. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Glass LF, Pepine ML, Fenske NA, Jaroszeski
M, Reintgen DS and Heller R: Bleomycin-mediated electrochemotherapy
of metastatic melanoma. Arch Dermatol. 132:1353–1357. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Mali B, Jarm T, Snoj M, Sersa G and
Miklavcic D: Antitumor effectiveness of electrochemotherapy: A
systematic review and meta-analysis. Eur J Surg Oncol. 39:4–16.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Marty M, Sersa G and Garbay JR:
Electrochemotherapy-An easy, highly effective and safe treatment of
cutaneous and subcutaneous metastases: Results of ESOPE (European
Standard Operating Procedures of Electrochemotherapy) study. Eur J
Cancer Suppl. 4:3–13. 2006. View Article : Google Scholar
|
|
64
|
Sersa G: The state-of-the-art of
electrochemotherapy before the ESOPE study: Advantages and clinical
uses. Eur J Cancer Suppl. 4:52–59. 2006. View Article : Google Scholar
|
|
65
|
Bertino G, Sersa G, De Terlizzi F, Occhini
A, Plaschke CC, Groselj A, Langdon C, Grau JJ, McCaul JA, Heuveling
D, et al: European research on electrochemotherapy in head and neck
Cancer (EURECA) project: Results of the treatment of skin cancer.
Eur J Cancer. 63:41–52. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Plaschke CC, Bertino G, McCaul JA, Grau
JJ, de Bree R, Sersa G, Occhini A, Groselj A, Langdon C, Heuveling
DA, et al: European Research on Electrochemotherapy in Head and
Neck Cancer (EURECA) project: Results from the treatment of mucosal
cancers. Eur J Cancer. 87:172–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Panje WR, Hier MP, Garman GR, Harrell E,
Goldman A and Bloch I: Electroporation therapy of head and neck
cancer. Ann Otol Rhinol Laryngol. 107:779–785. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Rabussay DP, Nanda GS and Goldfarb PM:
Enhancing the effectiveness of drug-based cancer therapy by
electroporation (electropermeabilization). Technol Cancer Res
Treat. 1:71–82. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bloom DC and Goldfarb PM: The role of
intratumour therapy with electroporation and bleomycin in the
management of advanced squamous cell carcinoma of the head and
neck. Eur J Surg Oncol. 31:1029–1035. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Larkin JO, Collins CG, Aarons S, Tangney
M, Whelan M, O'Reily S, Breathnach O, Soden DM and O'Sullivan GC:
Electrochemotherapy: Aspects of preclinical development and early
clinical experience. Ann Surg. 245:460–479. 2007. View Article : Google Scholar
|
|
71
|
Gargiulo M, Papa A, Capasso P, Moio M,
Cubicciotti E and Parascandolo S: Electrochemotherapy for
non-melanoma head and neck cancers: Clinical outcomes in 25
patients. Ann Surg. 255:1158–1164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Mevio N, Bertino G, Occhini A, Scelsi D,
Tagliabue M, Mura F and Benazzo M: Electrochemotherapy for the
treatment of recurrent head and neck cancers: Preliminary results.
Tumori. 98:308–313. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Seccia V, Muscatello L, Dallan I,
Bajraktari A, Briganti T, Ursino S, Galli L, Falcone A and
Sellari-Franceschini S: Electrochemotherapy and its controversial
results in patients with head and neck cancer. Anticancer Res.
34:967–972. 2014.PubMed/NCBI
|
|
74
|
Campana LG, Bertino G, Rossi CR, Occhini
A, Rossi M, Valpione S and Benazzo M: The value of
electrochemotherapy in the treatment of peristomal tumors. Eur J
Surg Oncol. 40:260–262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Campana LG, Mali B, Sersa G, Valpione S,
Giorgi CA, Strojan P, Miklavcic D and Rossi CR: Electrochemotherapy
in non-melanoma head and neck cancers: A retrospective analysis of
the treated cases. Br J Oral Maxillofac Surg. 52:957–964. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Macri GF, Greco A, Gallo A, Fusconi M,
Marinelli C and de Vincentiis M: Use of electrochemotherapy in a
case of neck skin metastasis of oral squamous cell carcinoma: Case
report and considerations. Head Neck. 36:E86–E90. 2014.PubMed/NCBI
|
|
77
|
Domanico R, Trapasso S, Santoro M,
Pingitore D and Allegra E: Electrochemotherapy in combination with
chemoradiotherapy in the treatment of oral carcinomas in advanced
stages of disease: efficacy, safety, and clinical outcomes in a
small number of selected cases. Drug Des Devel Ther. 9:1185–1191.
2015.PubMed/NCBI
|
|
78
|
Landstrom FJ, Reizenstein JA, Nilsson CO,
Beckerath MV, Löfgren AL, Adamsson GB and Möller C:
Electrochemotherapy-possible benefits and limitations to its use in
the head and neck region. Acta Otolaryngol. 135:90–95. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Landstrom FJ, Reizenstein J, Adamsson GB,
Beckerath Mv and Möller C: Long-term follow-up in patients treated
with curative electrochemotherapy for cancer in the oral cavity and
oropharynx. Acta Otolaryngol. 135:1070–1078. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Rotunno R, Marenco F, Ribero S, Calvieri
S, Amerio P, Curatolo P and Quaglino P: Electrochemotherapy in
non-melanoma head and neck skin cancers: a three-center experience
and review of the literature. G Ital Dermatol Venereol.
151:610–618. 2016.PubMed/NCBI
|
|
81
|
Montuori M, Santurro L, Feliziani A, DE
Sanctis F, Ricciardi E, Gaudio D, Campione E, Bianchi L, Silvi MB
and Rossi P: Electrochemotherapy for basocellular and
squamocellular head and neck cancer: preliminary experience in Day
Surgery Unit. G Ital Dermatol Venereol. 153:19–25. 2018.PubMed/NCBI
|
|
82
|
Groselj A, Bosnjak M, Strojan P, Krzan M,
Cemazar M and Sersa G: Efficiency of electrochemotherapy with
reduced bleomycin dose in the treatment of nonmelanoma head and
neck skin cancer: Preliminary results. Head Neck. 40:120–25. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Guida M, Campana LG, Curatolo P, Strippoli
S, Bonadies A, Grilz G, Cabula C, Rotunno R, Bucher S, Solari N, et
al: Local treatment with electrochemotherapy of superficial
angiosarcomas: Efficacy and safety results from a
multi-institutional retrospective study. J Surg Oncol. 114:246–253.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Jahangeer S, Forde P, Soden D and Hinchion
J: Review of current thermal ablation treatment for lung cancer and
the potential of electrochemotherapy as a means for treatment of
lung tumours. Cancer Treat Rev. 39:862–871. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Sersa G, Cufer T, Paulin SM, Cemazar M and
Snoj M: Electrochemotherapy of chest wall breast cancer recurrence.
Cancer Treat Rev. 38:379–386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Calvet CY and Mir LM: The promising
alliance of anti-cancer electrochemotherapy with immunotherapy.
Cancer Metastasis Rev. 35:165–177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Lenzi R, Muscatello L, Saibene AM,
Felisati G and Pipolo C: The controversial role of
electrochemotherapy in head and neck cancer: A systematic review of
the literature. Eur Arch Otorhinolaryngol. 274:2389–2394. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Miklavčič D, Serša G, Brecelj E, Gehl J,
Soden D, Bianchi G, Ruggieri P, Rossi CR, Campana LG and Jarm T:
Electrochemotherapy: technological advancements for efficient
electroporation-based treatment of internal tumors. Med Biol Eng
Comput. 50:1213–1225. 2012. View Article : Google Scholar : PubMed/NCBI
|
